Recent Quotes (30 days)

You have no recent quotes
chg | %

Mesa Laboratories, Inc.  

(Public, NASDAQ:MLAB)   Watch this stock  
Find more results for concentrations
+0.07 (0.08%)
Apr 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 86.45 - 87.74
52 week 46.27 - 95.97
Open 87.63
Vol / Avg. 13,922.00/18,692.00
Mkt cap 301.62M
P/E 39.47
Div/yield 0.15/0.69
EPS 2.22
Shares 3.45M
Beta 0.72
Inst. own 46%
May 26, 2014
Q4 2014 Mesa Laboratories Inc Earnings Release (Estimated) Add to calendar
Feb 3, 2014
Q3 2014 Mesa Laboratories Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 13.31% 18.20%
Operating margin 21.39% 28.22%
EBITD margin - 35.61%
Return on average assets 8.85% 14.49%
Return on average equity 12.17% 17.48%
Employees 215 -
CDP Score - -


12100 W. 6th. Avenue
United States - Map
+1-303-9878000 (Phone)
+1-303-9878989 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Mesa Laboratories, Inc. (Mesa)focuses on quality control products, which are sold into niche markets that are driven by regulatory requirements. The Company operates in two divisions across four physical locations. Its Instruments Division designs, manufactures and markets quality control instruments and disposable products utilized in connection with the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, semiconductor and petrochemical industries. Its Biological Indicators Division manufactures and markets biological indicators and distributes chemical indicators used to assess the effectiveness of sterilization processes, including steam, gas, hydrogen peroxide and radiation, in the hospital, dental, medical device and pharmaceutical industries. In April 2014, the Company acquired assets and certain liabilities of BGI Instruments Inc and BGI Inc both located in Waltham, MA.

Officers and directors

Luke R. Schmieder Independent Chairman of the Board
Age: 70
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John J. Sullivan Ph.D. President, Chief Executive Officer, Treasurer, Director
Age: 60
Bio & Compensation  - Reuters
John V. Sakys Chief Financial Officer, Executive Vice President, Chief Accounting Officer, Corporate Secretary
Age: 45
Bio & Compensation  - Reuters
Glenn E. Adriance Chief Sales and Marketing Officer
Age: 59
Bio & Compensation  - Reuters
Robert V. Dwyer Director
Age: 72
Bio & Compensation  - Reuters
Michael T. Brooks Independent Director
Age: 64
Bio & Compensation  - Reuters
H. Stuart Campbell Independent Director
Age: 83
Bio & Compensation  - Reuters
Evan C. Guillemin Independent Director
Age: 47
Bio & Compensation  - Reuters
David M. Kelly Independent Director
Age: 71
Bio & Compensation  - Reuters